DK0408524T3 - (Pyrrolidin-2-on-1-yl)acetamider til forøgelse af indlæring og hukommelse samt farmaceutiske præparater indeholdende sådanne - Google Patents
(Pyrrolidin-2-on-1-yl)acetamider til forøgelse af indlæring og hukommelse samt farmaceutiske præparater indeholdende sådanneInfo
- Publication number
- DK0408524T3 DK0408524T3 DK90830317.5T DK90830317T DK0408524T3 DK 0408524 T3 DK0408524 T3 DK 0408524T3 DK 90830317 T DK90830317 T DK 90830317T DK 0408524 T3 DK0408524 T3 DK 0408524T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrrolidin
- acetamides
- learning
- aminoethyl
- carbonylmethyl
- Prior art date
Links
- 230000006993 memory improvement Effects 0.000 title 1
- SIXPSGNZQPKXTG-UHFFFAOYSA-N n-(2-oxopyrrolidin-1-yl)acetamide Chemical class CC(=O)NN1CCCC1=O SIXPSGNZQPKXTG-UHFFFAOYSA-N 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 abstract 3
- -1 3-(pyrrolidin-2-one-1-yl) propyl Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical class NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- MQDVUDAZJMZQMF-UHFFFAOYSA-N pyridin-2-ylurea Chemical compound NC(=O)NC1=CC=CC=N1 MQDVUDAZJMZQMF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8948180A IT1231477B (it) | 1989-07-12 | 1989-07-12 | (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0408524T3 true DK0408524T3 (da) | 1995-12-11 |
Family
ID=11265047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90830317.5T DK0408524T3 (da) | 1989-07-12 | 1990-07-10 | (Pyrrolidin-2-on-1-yl)acetamider til forøgelse af indlæring og hukommelse samt farmaceutiske præparater indeholdende sådanne |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5061725A (el) |
| EP (1) | EP0408524B1 (el) |
| JP (1) | JPH0348657A (el) |
| AT (1) | ATE129996T1 (el) |
| DE (1) | DE69023400T2 (el) |
| DK (1) | DK0408524T3 (el) |
| ES (1) | ES2079469T3 (el) |
| GR (1) | GR3018032T3 (el) |
| IT (1) | IT1231477B (el) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1247698B (it) * | 1990-06-21 | 1994-12-30 | Sigma Tau Ind Farmaceuti | 1-alchil-3-(acilammino)-e-caprolattami quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| IT1243702B (it) * | 1990-08-08 | 1994-06-21 | Pulitzer Italiana | Composti ad attivita' nootropa, procedimento per la loro preparazione e relative composizioni farmaceutiche |
| SK279285B6 (sk) * | 1991-05-02 | 1998-09-09 | Daiichi Pharmaceutical Co. | Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin |
| IT1245870B (it) * | 1991-06-05 | 1994-10-25 | Sigma Tau Ind Farmaceuti | 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
| US7608636B2 (en) | 2000-12-28 | 2009-10-27 | Hamilton Pharmaceuticals, Inc. | Medicines for treatment and prevention of neurogenic pain |
| CN102227217A (zh) | 2008-10-16 | 2011-10-26 | 约翰斯.霍普金斯大学 | 改善认知功能的方法和组合物 |
| EP2533645B1 (en) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| BR112014006600B1 (pt) * | 2011-09-19 | 2022-04-19 | Alfasigma S.P.A. | Composto, composição farmacêutica contendo o referido composto, uso de um composto e processo para a sintetização de compostos |
| EP2919788A4 (en) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA |
| DK2968220T3 (da) | 2013-03-15 | 2021-06-14 | Agenebio Inc | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| BR112017025031B1 (pt) | 2015-05-22 | 2023-03-21 | Agenebio, Inc | Composições farmacêuticas de liberação prolongada de levetiracetam |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
| IT1141287B (it) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
| US4372960A (en) * | 1980-12-12 | 1983-02-08 | Warner-Lambert Company | Quaternary derivatives of N-(substituted-aminoalkyl)-2-oxo-1-pyrrolidine-acetamides as cognition activators |
| EP0089900B1 (en) * | 1982-03-24 | 1985-12-27 | Prodes S.A. | New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts |
| DE3326724A1 (de) * | 1983-07-25 | 1985-02-07 | Boehringer Ingelheim KG, 6507 Ingelheim | In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte |
| DE3336024A1 (de) * | 1983-10-04 | 1985-04-18 | Boehringer Ingelheim KG, 6507 Ingelheim | 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel |
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| IT1224168B (it) * | 1986-08-01 | 1990-09-26 | Finanziaria R F Spa Ora Finanz | Derivati del pirrolidin-2-one ad attivita' nootropa |
| CA1322199C (en) * | 1987-07-15 | 1993-09-14 | Masami Eigyo | N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia |
| JPH0696575B2 (ja) * | 1987-09-17 | 1994-11-30 | 三菱化成株式会社 | ４−アミノピリジン誘導体及びその酸付加塩 |
-
1989
- 1989-07-12 IT IT8948180A patent/IT1231477B/it active
-
1990
- 1990-07-10 EP EP90830317A patent/EP0408524B1/en not_active Expired - Lifetime
- 1990-07-10 ES ES90830317T patent/ES2079469T3/es not_active Expired - Lifetime
- 1990-07-10 DE DE69023400T patent/DE69023400T2/de not_active Expired - Fee Related
- 1990-07-10 AT AT90830317T patent/ATE129996T1/de active
- 1990-07-10 DK DK90830317.5T patent/DK0408524T3/da active
- 1990-07-11 JP JP2185173A patent/JPH0348657A/ja active Pending
- 1990-07-12 US US07/551,951 patent/US5061725A/en not_active Expired - Fee Related
-
1995
- 1995-11-09 GR GR940402281T patent/GR3018032T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE129996T1 (de) | 1995-11-15 |
| GR3018032T3 (en) | 1996-02-29 |
| IT8948180A0 (it) | 1989-07-12 |
| JPH0348657A (ja) | 1991-03-01 |
| EP0408524A1 (en) | 1991-01-16 |
| IT1231477B (it) | 1991-12-07 |
| DE69023400D1 (de) | 1995-12-14 |
| DE69023400T2 (de) | 1996-05-02 |
| EP0408524B1 (en) | 1995-11-08 |
| US5061725A (en) | 1991-10-29 |
| ES2079469T3 (es) | 1996-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0408524T3 (da) | (Pyrrolidin-2-on-1-yl)acetamider til forøgelse af indlæring og hukommelse samt farmaceutiske præparater indeholdende sådanne | |
| SE7906722L (sv) | Merkaptoacylderivat av substituerade proliner | |
| IL66650A (en) | Dibenzoxepines and dibenzooxazepines,their preparation and pharmaceutical compositions containing them | |
| NO971415D0 (no) | Aminoheterocykliske derivater som anti-trombose- eller antikoagulantmidler | |
| KR920006314A (ko) | 아릴알킬아민, 이의 제조방법 및 이를 함유하는 약제학적 조성물 | |
| NO175479C (no) | Analogifremgangsmåte ved fremstilling av 1-aza-tricyklo-(7,2,0,0.3,8)undec-2-en-2-karboksylat-derivater | |
| ES2149537T3 (es) | Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma. | |
| KR900018085A (ko) | 허혈방지제로서의 2- 피페리디노-1- 알칸올 유도체 | |
| PT91575A (pt) | Procede de preparation de benzylamines disubstituees utiles comme medicaments | |
| DK359387D0 (da) | Oploesninger af oxazaphosphoriner med forbedret stabilitet og fremgangsmaade til deres fremstilling | |
| DE3852107D1 (de) | Bestimmte 3-substituierte 2-alkyl-benzofuran-derivate. | |
| DK629889D0 (da) | Aminosyrederivater, deres fremstilling og anvendelse som laegemidler | |
| PT96788A (pt) | Processo de preparacao de compostos de ureia substituida e de composicoes farmaceuticas | |
| ATE112552T1 (de) | Harnstoffderivate, ihre herstellung und deren enthaltende arzneimittel. | |
| DK0412058T3 (da) | 1-Acyl-2-pyrrolidinoner som indlærings- og hukommelsesforstærkende midler og farmaceutiske præparater indeholdende disse forbindelser | |
| ZA912618B (en) | 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them | |
| DK624989D0 (da) | Hidtil ukendte forbindelser | |
| SE8303913L (sv) | Heterocykliska foreningar | |
| ATE116855T1 (de) | 3-amino-epsilon-caprolactam enthaltende pharmazeutische zusammensetzungen zur verbesserung des lernvermögens und des gedächtnisses. | |
| DE59206593D1 (de) | Verwendung von 2-Iminothiazolidin-4-onderivaten als neuartige Arzneimittelwirkstoffe | |
| KR960007560A (ko) | 신규한 아민 유도체, 그의 제조방법 및 항부정맥제로서의 용도 | |
| NO960308L (no) | Terapeutisk aktive benzoksaziner og benzotioanoner | |
| KR840006653A (ko) | 아크리다논 유도체의 제조방법 | |
| DE59308970D1 (de) | Oxazolidin Verbindungen und ihre Verwendung als Arzneimittel | |
| DK0493346T3 (da) | Derivater af 1,2,3,4-tetrahydronaphthylamin med nootrop aktivitet og farmaceutiske præparater indeholdende samme |